Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

Muhammad Usman Mirza; Atefeh Saadabadi; Michiel Vanmeert; Outi M.H. Salo-Ahen; Iskandar Abdullah; Sandra Claes; Steven De Jonghe; Dominique Schols; Sarfraz Ahmad; Matheus Froeyen

doi:10.1016/j.ejps.2021.105827

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

Muhammad Usman Mirza, Atefeh Saadabadi, Michiel Vanmeert, Outi M.H. Salo-Ahen, Iskandar Abdullah, Sandra Claes, Steven De Jonghe, Dominique Schols, Sarfraz Ahmad, Matheus Froeyen^*

^*Corresponding author for this work

Research output: Other contribution › peer-review

1 Citation (Scopus)

Abstract

The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.

Original language	English
Volume	162
DOIs	https://doi.org/10.1016/j.ejps.2021.105827
Publication status	Published - 1 Jul 2021
MoE publication type	O2 Other

Publication series

Name	European Journal of Pharmaceutical Sciences
Publisher	Elsevier
ISSN (Print)	0928-0987

Funding

This work was supported by the Finnish National Agency for Education [EDUFI Fellowship TM-17-10725 for A.S.].

Access to Document

10.1016/j.ejps.2021.105827

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)'. Together they form a unique fingerprint.

Cite this

Mirza, M. U., Saadabadi, A., Vanmeert, M., Salo-Ahen, O. M. H., Abdullah, I., Claes, S., De Jonghe, S., Schols, D., Ahmad, S., & Froeyen, M. (2021, Jul 1). Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537). https://doi.org/10.1016/j.ejps.2021.105827

Mirza, Muhammad Usman ; Saadabadi, Atefeh ; Vanmeert, Michiel et al. / Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537). 2021. (European Journal of Pharmaceutical Sciences).

@misc{20c74df4670943039e04de6c94db5ba0,

title = "Corrigendum to {\textquoteleft}Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach{\textquoteright} [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)",

abstract = "The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.",

author = "Mirza, \{Muhammad Usman\} and Atefeh Saadabadi and Michiel Vanmeert and Salo-Ahen, \{Outi M.H.\} and Iskandar Abdullah and Sandra Claes and \{De Jonghe\}, Steven and Dominique Schols and Sarfraz Ahmad and Matheus Froeyen",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/j.ejps.2021.105827",

language = "English",

volume = "162",

series = "European Journal of Pharmaceutical Sciences",

publisher = "Elsevier",

type = "Other",

}

Mirza, MU, Saadabadi, A, Vanmeert, M, Salo-Ahen, OMH, Abdullah, I, Claes, S, De Jonghe, S, Schols, D, Ahmad, S & Froeyen, M 2021, Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537).. https://doi.org/10.1016/j.ejps.2021.105827

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537). / Mirza, Muhammad Usman; Saadabadi, Atefeh; Vanmeert, Michiel et al.
2021. (European Journal of Pharmaceutical Sciences).

Research output: Other contribution › peer-review

TY - GEN

T1 - Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

AU - Mirza, Muhammad Usman

AU - Saadabadi, Atefeh

AU - Vanmeert, Michiel

AU - Salo-Ahen, Outi M.H.

AU - Abdullah, Iskandar

AU - Claes, Sandra

AU - De Jonghe, Steven

AU - Schols, Dominique

AU - Ahmad, Sarfraz

AU - Froeyen, Matheus

PY - 2021/7/1

Y1 - 2021/7/1

N2 - The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.

AB - The authors regret that the Acknowledgements section was missing from the original published version of the article. Acknowledgement should have been published as below.

UR - https://www.scopus.com/pages/publications/85103592235

U2 - 10.1016/j.ejps.2021.105827

DO - 10.1016/j.ejps.2021.105827

M3 - Other contribution

C2 - 33814256

AN - SCOPUS:85103592235

VL - 162

T3 - European Journal of Pharmaceutical Sciences

ER -

Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537](S0928098720303250)(10.1016/j.ejps.2020.105537)

Abstract

Publication series

Funding

Access to Document

Other files and links

Fingerprint

Cite this